- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 14:18 | Adia Med submits fifth clinical study protocol for 2026 | 2 | Investing.com | ||
| 14:02 | Adia Med Inc.: Adia Med Submits Fifth 2026 Clinical Study to IRB: Osteoarthritis Protocol for One-Time Systemic Treatment | 69 | Newsfile | Winter Park, Florida--(Newsfile Corp. - September 15, 2026) - Adia Med Inc. (OTCQB: ADIA), a regenerative medicine company, today announced that its subsidiary, Adia Med of Winter Park, LLC, has submitted... ► Artikel lesen | |
| ADIA MED Aktie jetzt für 0€ handeln | |||||
| 08.09. | Adia Med Inc.: Nasdaq Shareholder Requirements Just Verified By Adia Med | 203 | Newsfile | Winter Park, Florida--(Newsfile Corp. - September 8, 2026) - Nasdaq requires companies seeking an initial listing on the Nasdaq Capital Market to have a sufficiently broad public shareholder base. That... ► Artikel lesen | |
| 24.08. | Adia Med engages law firm for planned Nasdaq uplisting | 3 | Investing.com | ||
| 24.08. | Adia Med Inc.: Adia Med Inc. Engages Lucosky Brookman LLP as Legal Counsel for Planned NASDAQ Uplisting | 271 | Newsfile | Winter Park, Florida--(Newsfile Corp. - August 24, 2026) - Adia Med Inc. (OTCQB: ADIA) today announced that it has entered into an engagement letter with Lucosky Brookman LLP ("Lucosky Brookman")... ► Artikel lesen | |
| 17.08. | FINRA genehmigt Umfirmierung: Adia Nutrition wird zu Adia Med | 1 | Investing.com Deutsch | ||
| 17.08. | Adia Nutrition, Inc. - 8-K, Current Report | - | SEC Filings | ||
| 14.08. | Adia Med reports Q2 results | 1 | Seeking Alpha | ||
| 13.08. | Adia Med Inc.: Adia Med Delivers Record Q2 Results: $485K Revenue, First Net Profit, and Nearly Matches Full-Year 2025 Revenue in First Half | 600 | Newsfile | Winter Park, Florida--(Newsfile Corp. - August 13, 2026) - Adia Med Inc. (OTCQB: ADIA), a regenerative medicine company focused on stem cell therapies, biologics, and advanced clinical services... ► Artikel lesen | |
| 13.08. | Adia Nutrition, Inc. - 10-Q, Quarterly Report | 5 | SEC Filings | ||
| 11.08. | Adia Med Inc.: Adia Med Partners with Full Sail University; CEO Larry Powalisz to Present Company and Explore Student Assistance with SEO, Social Media, and Marketing | 243 | Newsfile | Winter Park, Florida--(Newsfile Corp. - August 11, 2026) - Adia Med Inc. (OTCQB: ADIA), a regenerative medicine company focused on stem cell therapies and biologics, today announced a new educational... ► Artikel lesen | |
| 05.08. | Adia Med Inc.: Adia Med to Host Dinner for Physicians at Christner's Steakhouse on August 5 to Discuss Clinical Studies and Collaboration Opportunities | 569 | Newsfile | Winter Park, Florida--(Newsfile Corp. - August 5, 2026) - Adia Med Inc. (OTCQB: ADIA), a regenerative medicine company focused on stem cell therapies and biologics, today announced that it will... ► Artikel lesen | |
| 29.07. | Adia Med advances autism study to phase 2, enrolls new cohort | 2 | Investing.com | ||
| 29.07. | Adia Med Inc.: Adia Med Completes Phase 1 and Formally Launches Phase 2 of Autism Spectrum Disorder Clinical Study | 291 | Newsfile | Winter Park, Florida--(Newsfile Corp. - July 29, 2026) - Adia Med Inc. (OTCQB: ADIA) today announced two distinct milestones in its Autism Spectrum Disorder (ASD) clinical research study (ClinicalTrials.gov... ► Artikel lesen | |
| 15.07. | Adia Med Inc.: Adia Med Inc. (Formerly Adia Nutrition Inc.) Launches Redesigned Corporate Website | 555 | Newsfile | Winter Park, Florida--(Newsfile Corp. - July 15, 2026) - Adia Med Inc. (OTCQB: ADIA), a clinical-stage regenerative medicine company, today announced the launch of its redesigned corporate website.... ► Artikel lesen | |
| 13.07. | Adia Med Inc.: Adia Med's Rise, Highlighting 2.5 Years of Growth Toward NASDAQ | 354 | Newsfile | Winter Park, Florida--(Newsfile Corp. - July 13, 2026) - Adia Med Inc. (OTCQB: ADIA) (formerly Adia Nutrition Inc.), focused on regenerative medicine, stem cell therapies, and biologics, today highlighted... ► Artikel lesen | |
| 09.07. | Adia Med Inc.: Adia Nutrition to Trade as Adia Med Inc. After Lightning-Fast FINRA Review | 248 | Newsfile | Winter Park, Florida--(Newsfile Corp. - July 9, 2026) - Adia Nutrition, Inc. (OTCQB: ADIA) announced today that FINRA has processed its corporate name change to Adia Med Inc. on an expedited timeline.... ► Artikel lesen | |
| 07.07. | Adia Nutrition nears final approval for name change to Adia Med | 1 | Investing.com | ||
| 07.07. | Adia Nutrition Inc.: Adia Nutrition Inc. Enters FINRA Home Stretch for Corporate Name Change to Adia Med Inc. | 522 | Newsfile | Winter Park, Florida--(Newsfile Corp. - July 7, 2026) - Adia Nutrition Inc. (OTCQB: ADIA) today announced it has entered the final stage of its corporate name change application from Adia Nutrition... ► Artikel lesen | |
| 30.06. | Adia Nutrition Inc.: Adia Med Finds Another Unicorn | 416 | Newsfile | Winter Park, Florida--(Newsfile Corp. - June 30, 2026) - Adia Med Inc. (OTCQB: ADIA), a regenerative medicine and stem cell therapies company, today announced that CEO Larry Powalisz recently sat... ► Artikel lesen |
1 2 3 4 Weiter >>
73 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| HEARTFLOW | 49,540 | 0,00 % | Heartflow, Inc.: Late Breaking Data from Independent Government-Funded Trial at ESC Shows Heartflow FFRCT Analysis Reduces Unnecessary Invasive Heart Procedures by Nearly Half | FUSION trial presented at ESC and published in Journal of the American College of Cardiology demonstrates adding non-invasive lesion-specific physiology resolves critical diagnostic uncertainty, supporting... ► Artikel lesen | |
| BRIGHTSPRING HEALTH SERVICES | 60,27 | -0,05 % | BrightSpring Health Services auf Jefferies-Konferenz: Wachstum auf breiter Front | ||
| ALIGNMENT HEALTHCARE | 12,935 | 0,00 % | Alignment Healthcare USA, LLC: Alignment Health's Fifth Annual Survey Finds Seniors Falling Further Behind: Aging in Place Challenges Continue to Rise as Support Gaps Widen | ||
| FRESENIUS | 45,410 | -0,65 % | EQS-DD: Fresenius SE & Co. KGaA: Michael Sen, Kauf | Meldung und öffentliche Bekanntgabe der Geschäfte von Personen, die Führungsaufgaben wahrnehmen, sowie in enger Beziehung zu ihnen stehenden Personen
08.09.2026 / 11:02... ► Artikel lesen | |
| BASEL MEDICAL GROUP | 7,180 | +0,56 % | Morning Market Movers: Aehr Test Systems, Pentair, NextCure, Basel Medical Group See Big Swings | BEIJING (dpa-AFX) - At 8:30 a.m. ET on Wednesday, premarket trading is seeing notable activity in several stocks, with early price movements signaling potential opportunities before the opening... ► Artikel lesen | |
| AVEANNA HEALTHCARE | 14,395 | +0,10 % | Biotech Stocks At 52-Week Highs - Park Dental Partners +10%, Aveanna Healthcare +24%, Candel Therapeutics +10% on Q2 Reports, Labcorp Holdings, Hemab Therapeutics | LONDON (dpa-AFX) - The following biotech stocks reached 52-week highs on August 13, 2026, driven by key catalysts such as positive quarterly reports and the issuance of increased guidance figures.Park... ► Artikel lesen | |
| LIFESTANCE HEALTH GROUP | 13,390 | 0,00 % | LifeStance Health Group, Inc. - 8-K, Current Report | ||
| FRESENIUS MEDICAL CARE | 39,830 | +0,68 % | EQS-PVR: Fresenius Medical Care AG: Veröffentlichung über Erwerb oder Veräußerung eigener Aktien nach § 40 Abs. 1 Satz 2 WpHG | EQS Stimmrechtsmitteilung: Fresenius Medical Care AG
Fresenius Medical Care AG: Veröffentlichung über Erwerb oder Veräußerung eigener Aktien nach § 40 Abs. 1 Satz 2 WpHG
10.09.2026... ► Artikel lesen | |
| PROCEPT BIOROBOTICS | 21,025 | 0,00 % | Oppenheimer reiterates Procept BioRobotics stock rating | ||
| STARLING ONCOLOGY INSTITUTE | 6,520 | 0,00 % | The Oncology Institute Rebrands as Starling Oncology | CERRITOS, Calif., Aug. 03, 2026 (GLOBE NEWSWIRE) -- The Oncology Institute, Inc. ("TOI" or "the Company"), one of the largest value-based oncology groups in the United States, announced today that... ► Artikel lesen | |
| GENEDX | 89,77 | +0,03 % | GeneDx: Starkes Wachstum trifft auf schwachen Forderungseinzug | ||
| BETA BIONICS | 16,710 | -0,12 % | Beta Bionics, Inc.: Beta Bionics Announces FDA Clearance of Mint, the Company's Transformative Patch Pump, and Unveils 3D Intelligence as its Next-Generation Insulin Dosing Algorithm | Mint features a new and innovative patch pump architecture Full Mint U.S. commercialization expected to begin in Q1 2027 Manufacturing capacity expected to produce at least 1.5 million disposable... ► Artikel lesen | |
| SIEMENS HEALTHINEERS | 39,060 | +0,18 % | JPMORGAN stuft Siemens Healthineers auf 'Overweight' | NEW YORK (dpa-AFX Analyser) - Die US-Bank JPMorgan hat Siemens Healthineers auf "Overweight" belassen. Die Experten Anchal Verma und David Adlington bleiben für die europäischen Medizintechnikunternehmen... ► Artikel lesen | |
| BILLIONTOONE | 100,78 | -0,04 % | BillionToOne Appoints Ethan Dmitrovsky, MD, as Chief Medical Officer, Oncology, to Lead Medical Strategy for Northstar | Renowned physician-scientist, former Director of Frederick National Laboratory, and one of the nation's most accomplished leaders in oncology joins BillionToOne... ► Artikel lesen | |
| PRIVIA HEALTH GROUP | 20,880 | 0,00 % | Privia Health Group, Inc.: Privia Health Announces Appointment of Opella Ernest, M.D. to its Board of Directors | ARLINGTON, Va., Aug. 18, 2026 (GLOBE NEWSWIRE) -- Privia Health Group, Inc. (Nasdaq: PRVA) announced the appointment of Opella Ernest, M.D. to its Board of Directors, effective September 1, 2026.... ► Artikel lesen |
ADIA MED INC gehört der Branche Gesundheitswesen an.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu ADIA MED INC finden Sie auf Wallstreet Online.